A 2012 analysis of data from REVEAL found that 46% of patients with PAH are being treated with dual agents and 9% are on triple therapy. 19 Notable from the research, and reflected in the ...
Medpage Today on MSN2mon
Have the New Pulmonary Hypertension Drugs Changed the Game?These data were especially impressive given that patients had long-standing disease, were quite ill, and heavily treated (on ...
In patients who are newly diagnosed with PAH and treatment-naïve, initial combination therapy can improve symptoms, exercise capacity, and outcomes compared with those in individuals who receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback